{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:09:43Z","timestamp":1779376183341,"version":"3.53.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s12010-026-05642-9","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T09:45:45Z","timestamp":1773308745000},"page":"4105-4114","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Recombinant Fusion Protein Composed of Hirudin and Annexin A5 Shows Anti-Coagulant Activity In Vitro"],"prefix":"10.1007","volume":"198","author":[{"given":"Hao","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chufan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"key":"5642_CR1","doi-asserted-by":"publisher","first-page":"470016","DOI":"10.3389\/fmed.2020.470016","volume":"7","author":"PL Gross","year":"2020","unstructured":"Gross, P. L., & Chan, N. C. (2020). Thromboembolism in older adults. Frontiers in Medicine, 7, 470016.","journal-title":"Front Med"},{"key":"5642_CR2","doi-asserted-by":"publisher","first-page":"100788","DOI":"10.1016\/j.blre.2020.100788","volume":"48","author":"C Cheng","year":"2021","unstructured":"Cheng, C., Cheng, G. Y., Denas, G., & Pengo, V. (2021). Arterial thrombosis in antiphospholipid syndrome (APS): Clinical approach and treatment. A systematic review. Blood Reviews, 48, 100788.","journal-title":"Blood Reviews"},{"key":"5642_CR3","doi-asserted-by":"publisher","first-page":"e480","DOI":"10.1161\/CIRCULATIONAHA.108.841403","volume":"119","author":"S Rathbun","year":"2009","unstructured":"Rathbun, S. (2009). Cardiology patient pages. The surgeon general\u2019s call to action to prevent deep vein thrombosis and pulmonary embolism. Circulation, 119, e480\u2013e482.","journal-title":"Circulation"},{"key":"5642_CR4","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1378\/chest.122.3.960","volume":"122","author":"PD Stein","year":"2002","unstructured":"Stein, P. D., Patel, K. C., Kalra, N. K., El Baage, T. Y., Savarapu, P., Silbergleit, A., & Check, F. E. (2002). Deep venous thrombosis in a general hospital. Chest, 122, 960\u2013962.","journal-title":"Chest"},{"key":"5642_CR5","doi-asserted-by":"publisher","first-page":"102190","DOI":"10.1016\/j.ctrv.2021.102190","volume":"96","author":"C Becattini","year":"2021","unstructured":"Becattini, C., Di Nisio, M., Franco, L., Lee, A., Agnelli, G., & Mandal\u00e0, M. (2021). Treatment of venous thromboembolism in cancer patients: The dark side of the moon. Cancer Treatment Reviews, 96, 102190.","journal-title":"Cancer Treatment Reviews"},{"key":"5642_CR6","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3122\/jabfm.2021.02.200085","volume":"34","author":"TM Fernandes","year":"2021","unstructured":"Fernandes, T. M., Kanwar, M., & White, R. (2021). Management of patients with venous thromboembolism after the initial treatment period. Journal of the American Board of Family Medicine : Jabfm, 34, 409\u2013419.","journal-title":"Journal Of The American Board Of Family Medicine : Jabfm"},{"key":"5642_CR7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1177\/0897190018767769","volume":"33","author":"LA Igneri","year":"2020","unstructured":"Igneri, L. A., & Hammer, J. M. (2020). Systemic thrombolytic therapy for massive and submassive pulmonary embolism. Journal of Pharmacy Practice, 33, 74\u201389.","journal-title":"Journal Of Pharmacy Practice"},{"key":"5642_CR8","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1111\/bjh.14714","volume":"178","author":"J Czuprynska","year":"2017","unstructured":"Czuprynska, J., Pate l, J. P., & Arya, R. (2017). Current challenges and future prospects in oral anticoagulant therapy. British Journal of Haematology, 178, 838\u2013851.","journal-title":"British Journal Of Haematology"},{"key":"5642_CR9","doi-asserted-by":"publisher","first-page":"7975","DOI":"10.3390\/ijms21217975","volume":"21","author":"A Lichota","year":"2020","unstructured":"Lichota, A., Szewczyk, E. M., & Gwozdzinski, K. (2020). Factors affecting the formation and treatment of thrombosis by natural and synthetic compounds. International Journal of Molecular Sciences, 21, 7975.","journal-title":"International Journal Of Molecular Sciences"},{"key":"5642_CR10","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1177\/1089253207311154","volume":"11","author":"AF Merry","year":"2007","unstructured":"Merry, A. F. (2007). Focus on thrombin: Alternative anticoagulants. Seminars in Cardiothoracic and Vascular Anesthesia, 11, 256\u2013260.","journal-title":"Seminars In Cardiothoracic And Vascular Anesthesia"},{"key":"5642_CR11","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/sj.bjp.0703137","volume":"129","author":"E Gandossi","year":"2000","unstructured":"Gandossi, E., Lunven, C., & Berry, C. N. (2000). Role of clot-associated (-derived) thrombin in cell proliferation induced by fibrin clots in vitro. British Journal of Pharmacology, 129, 1021\u20131027.","journal-title":"British Journal Of Pharmacology"},{"key":"5642_CR12","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1161\/01.CIR.97.7.681","volume":"97","author":"BJ Meyer","year":"1998","unstructured":"Meyer, B. J., Badimon, J. J., Chesebro, J. H., Fallon, J. T., Fuster, V., & Badimon, L. (1998). Dissolution of mural thrombus by specific thrombin inhibition with r-hirudin: comparison with heparin and aspirin. Circulation, 97, 681\u2013685.","journal-title":"Circulation"},{"issue":"Suppl 3","key":"5642_CR13","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1378\/chest.126.3_suppl.549S","volume":"126","author":"V Menon","year":"2004","unstructured":"Menon, V., Harrington, R. A., Hochman, J. S., Cannon, C. P., Goodman, S. D., Wilcox, R. G., Sch\u00fcnemann, H. J., & Ohman, E. M. (2004). Thrombolysis and adjunctive therapy in acute myocardial infarction: The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest, 126(Suppl 3), 549\u2013575.","journal-title":"Chest"},{"key":"5642_CR14","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1055\/s-2002-35293","volume":"28","author":"G Nowak","year":"2002","unstructured":"Nowak, G. (2002). Pharmacology of recombinant hirudin. Seminars in Thrombosis and Hemostasis, 28, 415\u2013424.","journal-title":"Seminars In Thrombosis And Hemostasis"},{"key":"5642_CR15","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1089\/dna.1.1986.5.511","volume":"5","author":"E Fortkamp","year":"1986","unstructured":"Fortkamp, E., Rieger, M., Heisterberg-Moutses, G., Schweitzer, S., & Sommer, R. (1986). Cloning and expression in Escherichia coli of a synthetic DNA for hirudin, the blood coagulation inhibitor in the leech. DNA, 5, 511\u2013517.","journal-title":"DNA"},{"key":"5642_CR16","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1055\/s-2007-1002721","volume":"15","author":"M Courtney","year":"1989","unstructured":"Courtney, M., Loison, G., Lemoine, Y., Riehl-Bellon, N., Degryse, E., Brown, S. W., Cazenave, J. P., Defreyn, G., Delebassee, D., Bernat, A., et al. (1989). Production and evaluation of recombinant hirudin. Seminars in Thrombosis and Hemostasis, 15, 288\u2013292.","journal-title":"Seminars In Thrombosis And Hemostasis"},{"key":"5642_CR17","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1161\/01.CIR.103.10.1479","volume":"103","author":"A Greinacher","year":"2001","unstructured":"Greinacher, A., & Lubenow, N. (2001). Recombinant hirudin in clinical practice: focus on lepirudin. Circulation, 103, 1479\u20131484.","journal-title":"Circulation"},{"key":"5642_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1432-1033.1992.tb17392.x","volume":"210","author":"A Lewit-Bentley","year":"1992","unstructured":"Lewit-Bentley, A., Morera, S., Huber, R., & Bodo, G. (1992). The effect of metal binding on the structure of annexin V and implications for membrane binding. European Journal of Biochemistry, 210, 73\u201377.","journal-title":"European Journal of Biochemistry"},{"key":"5642_CR19","doi-asserted-by":"publisher","first-page":"24302","DOI":"10.1016\/S0021-9258(18)54228-9","volume":"266","author":"P Thiagarajan","year":"1991","unstructured":"Thiagarajan, P., & Tait, J. F. (1991). Collagen-induced exposure of anionic phospholipid in platelets and platelet-derived microparticles. Journal of Biological Chemistry, 266, 24302\u201324307.","journal-title":"Journal Of Biological Chemistry"},{"key":"5642_CR20","doi-asserted-by":"publisher","first-page":"11107","DOI":"10.1016\/S0021-9258(17)39154-8","volume":"260","author":"SJ Shattil","year":"1985","unstructured":"Shattil, S. J., Hoxie, J. A., Cunningham, M., & Brass, L. F. (1985). Changes in the platelet membrane glycoprotein IIb. IIIa complex during platelet activation. Journal of Biological Chemistry, 260, 11107\u201311114.","journal-title":"Journal Of Biological Chemistry"},{"key":"5642_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/0378-1119(88)90005-4","volume":"67","author":"DB Smith","year":"1988","unstructured":"Smith, D. B., & Johnson, K. S. (1988). Single-step purification of polypeptide expressed in escherichia coli as fusions with glutathione-S-transferase. Gene, 67, 31\u201340.","journal-title":"Gene"},{"key":"5642_CR22","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1182\/blood-2005-04-1710","volume":"106","author":"DA Lane","year":"2005","unstructured":"Lane, D. A., Philippou, H., & Huntington, J. A. (2005). Directing thrombin. Blood, 106, 2605\u20132612.","journal-title":"Blood"},{"key":"5642_CR23","first-page":"277","volume":"21","author":"C Li","year":"2001","unstructured":"Li, C., Huang, J., & Yang, G. (2001). A rabbit femoral artery thrombosis model induced by balloon injury. Journal of Nanjing Medical University, 21, 277\u2013280.","journal-title":"Journal of Nanjing Medical University"},{"key":"5642_CR24","doi-asserted-by":"publisher","first-page":"17420","DOI":"10.1016\/S0021-9258(18)38177-8","volume":"265","author":"P Thiagarajan","year":"1990","unstructured":"Thiagarajan, P., & Tait, J. F. (1990). Binding of annexin V\/placental anticoagulant protein I to platelets. Evidence for phosphatidylserine exposure in the procoagulant response of activated platelets. Journal of Biological Chemistry, 265, 17420\u201317423.","journal-title":"Journal Of Biological Chemistry"},{"key":"5642_CR25","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/0049-3848(94)90224-0","volume":"75","author":"JF Tait","year":"1994","unstructured":"Tait, J. F., Cerqueira, M. D., Dewhurst, T. A., Fujikawa, K., Ritchie, J. L., & Stratton, J. R. (1994). Evaluation of annexin V as a platelet-directed thrombus targeting agent. Thrombosis Research, 75, 491\u2013501.","journal-title":"Thrombosis Research"},{"key":"5642_CR26","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1055\/s-2002-35283","volume":"28","author":"N Lubenow","year":"2002","unstructured":"Lubenow, N., & Greinacher, A. (2002). Hirudin in heparin-induced thrombocytopenia. Seminars in Thrombosis and Hemostasis, 28, 431\u2013438.","journal-title":"Seminars In Thrombosis And Hemostasis"},{"key":"5642_CR27","first-page":"362","volume":"5","author":"JY Fong","year":"2025","unstructured":"Fong, J. Y., Phuna, Z., Chong, D. Y., Heryanto, C. M., Low, Y. S., Oh, K. C., Lee, Y. H., Ng, A. W. R., In, L. L. A., & Teo, M. Y. M. (2025). Advancements in antibody-drug conjugates as cancer therapeutics. Journal of the National Cancer Center, 5, 362\u2013378.","journal-title":"J Natl Cancer Cent"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05642-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-026-05642-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05642-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:02:09Z","timestamp":1779375729000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-026-05642-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["5642"],"URL":"https:\/\/doi.org\/10.1007\/s12010-026-05642-9","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]},"assertion":[{"value":"23 February 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}